Clinical trial
A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in…
NCT00439426 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00439426 |
|---|---|
| Title | A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer. |
| Official title | An Open Label Study of First Line Chemotherapy With Xeloda in Combination With Cisplatin on Treatment Response in Patients With Metastatic Nasopharyngeal Cancer |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Nasopharyngeal Cancer |
| Intervention type | Drug |
| Interventions | Oxaliplatin, capecitabine [Xeloda] |
| Enrollment | 25 |
| Start date | Apr 1, 2007 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Feb 23, 2007 |
| Last update posted | Nov 2, 2016 |
| Countries | Morocco |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: